Here are seven things to know for April 17, 2017.
Lee Health gets green light for $140M outpatient medical campus featuring surgery center
Florida-based Lee Health received board approval to build its new $140 million outpatient medical campus in Estero, Fla.
Price: Physicians should recommend new payment models: 5 points
As physician burnout rates continue to climb and physicians struggle to comply with CMS' many reporting requirements, HHS Secretary Tom Price, MD, said physicians should recommend ideas for new Medicare payment models. Dr. Price urged physicians to provide recommendations during the first Physician-Focused Payment Model Technical Advisory Committee meeting.
The Joint Commission names top 10 challenging standards for 2016
The Joint Commission named its top 10 most challenging standards in 2016 for ASCs and the number of ASCs facing these challenges. Some of the standards ASCs violate include:
Failing to reduce the risk of infections associated with medical equipment, devices and supplies — 53 percent
Failing to grant initial, renew or revise clinical privileges to individuals who are permitted by law and the organization to practice independently — 47 percent
Failing to maintain fire safety equipment or fire safety building features — 37 percent
Virtua's $1B medical campus with ASC one step closer to CON approval
The New Jersey State Health Planning Board voted to approve Evesham Township, N.J.-based Virtua's plans for a medical campus and hospital in Holly, N.J.
Ohio Gastroenterology & Liver Institute opens HyGIeaCare Center
The Ohio Gastroenterology & Liver Institute's Pradeep Bekal, MD, opened the HyGIeaCare Center in February. The HyGIeaCare Center features machines that improve bowel preparation quality. Both are located in Cleveland.
TeamHealth names medical directors, advanced practice clinician of the year
Knoxville, Tenn.-based TeamHealth named its 2017 Dr. Gar LaSalle Medical Directors of the Year and Advanced Practice Clinician of the Year awards.
Key Capital announces positive liver cancer immunotherapy results due to product use
Key Capital announced positive results for its liver cancer immunotherapy product hepcortespenlisimut-L. Hepcortespenlisimut-L is a once daily tablet of an oral immunotherapeutic vaccine. Key Capital proved it was safe and highly effective in treating 75 advanced liver cancer patients through a phase II study.